REG - Abbott Laboratories - Abbott Laboratories Files Form 8-K <Origin Href="QuoteRef">ABT.N</Origin>
RNS Number : 1321KAbbott Laboratories16 September 2016Notification to RNS
Company: Abbott Laboratories
TIDM: ABT
Headline: Abbott Laboratories Files Form 8-K
Abbott Laboratories (the "Company")
16 September 2016
Abbott Laboratories Files Form 8-K
The Company informs its shareholders that on 16 September 2016, in accordance with the U.S. Securities Exchange Act of 1934, as amended, a Current Report on Form 8-K ("Form 8-K") was filed with the U.S. Securities and Exchange Commission ("SEC"). The Form 8-K can be found on the SEC website at http://www.sec.gov.
A copy of the Form 8-K has been submitted to the National Storage Mechanism on the date of this announcement and is, or will shortly be, available for inspection at http://www.morningstar.co.uk/uk/NSM.
Issued by: Abbott Laboratories
CONTACT: Financial, Scott Leinenweber, +1-224-668-0791, or Media, Scott Stoffel, +1-224-668-5201.
This information is provided by RNSThe company news service from the London Stock ExchangeENDDOCSFWEFMFMSEFU
Recent news on Abbott Laboratories
See all newsABBOTT LABORATORIES INVESTIGATION REMINDER ALERT: Scott+Scott Attorneys at Law LLP Continues to Investigate Abbott Laboratories’ Directors and Officers for Breach of Fiduciary Duties – ABT
NewsNYSE ORDER IMBALANCE <Origin Href="QuoteRef">ABT.N</Origin> 66480.0 SHARES ON SELL SIDE
NewsUPDATE 1-Baby formula supplies improving, say U.S. retailers Walmart and Target
NewsNYSE ORDER IMBALANCE <Origin Href="QuoteRef">ABT.N</Origin> 63921.0 SHARES ON BUY SIDE
NewsWalmart says baby formula availability improving in its stores
News